RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
复制标题
RBBP6 增加放射抗性并可作为结直肠癌术前放疗的治疗靶点
DOI:
10.1111/cas.13516
复制
发表时间:
2018-04
期刊:
影响因子:
5.7
通讯作者:
Wang X
中科院分区:
文献类型:
--
作者:
Xiao C;Wang Y;Zheng M;Chen J;Song G;Zhou Z;Zhou C;Sun X;Zhong L;Ding E;Zhang Y;Yang L;Wu G;Xu S;Zhang H;Wang X
Radiotherapy (RT) can be used as preoperative treatment to downstage initially unresectable locally rectal carcinoma, but radioresistance and recurrence remain significant problems. Retinoblastoma binding protein 6 (RBBP6) has been implicated in the regulation of cell cycle, apoptosis and chemoresistance both in vitro and in vivo. The present study investigated whether the inhibition of RBBP6 expression would improve radiosensitivity in human colorectal cancer cells. After SW620 and HT29 cells were exposed to radiation, the levels of RBBP6 mRNA and protein increased over time in both cells. Moreover, a significant reduction in clonogenic survival and a decrease in cell viability in parallel with an obvious increase in cell apoptosis were demonstrated in irradiated RBBP6‐knockdown cells. Transfection with RBBP6 shRNA improved the levels of G2‐M phase arrest, which blocked the cells in a more radiosensitive period of the cell cycle. These observations indicated that cell cycle and apoptosis mechanisms may be connected with tumor cell survival following radiotherapy. In vivo, the tumor growth rate of nude mice in the RBBP6‐knockdown group was significantly slower than that in other groups. These results indicated that RBBP6 overexpression could resist colorectal cancer cells against radiation by regulating cell cycle and apoptosis pathways, and inhibition of RBBP6 could enhance radiosensitivity of human colorectal cancer.
登录
查看更多内容
影响因子:
4.3
作者:
Garg PK;Sharma J;Jakhetiya A;Goel A;Gaur MK
通讯作者:
Gaur MK
影响因子:
4
作者:
Moela P;Motadi LR
通讯作者:
Motadi LR
影响因子:
9.2
作者:
Li Y;Wang J;Ma X;Tan L;Yan Y;Xue C;Hui B;Liu R;Ma H;Ren J
通讯作者:
Ren J
影响因子:
3.3
作者:
Deng, Qian;Huang, Chun-mei;Wang, Wei
通讯作者:
Wang, Wei
DOI:
10.1136/jim-2016-000229
发表时间:
2017-03
期刊:
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
影响因子:
--
作者:
Bhandari A;Woodhouse M;Gupta S
通讯作者:
Gupta S